nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—GART—myometrium—uterine cancer	0.013	0.0454	CbGeAlD
Pemetrexed—GART—uterine cervix—uterine cancer	0.0102	0.0353	CbGeAlD
Pemetrexed—GART—decidua—uterine cancer	0.00967	0.0336	CbGeAlD
Pemetrexed—GART—renal system—uterine cancer	0.0095	0.033	CbGeAlD
Pemetrexed—GART—endometrium—uterine cancer	0.00918	0.0319	CbGeAlD
Pemetrexed—GART—mammalian vulva—uterine cancer	0.00888	0.0309	CbGeAlD
Pemetrexed—SLC46A1—decidua—uterine cancer	0.00785	0.0273	CbGeAlD
Pemetrexed—GART—female reproductive system—uterine cancer	0.00761	0.0265	CbGeAlD
Pemetrexed—ATIC—epithelium—uterine cancer	0.00695	0.0242	CbGeAlD
Pemetrexed—GART—female gonad—uterine cancer	0.00692	0.0241	CbGeAlD
Pemetrexed—GART—vagina—uterine cancer	0.00688	0.0239	CbGeAlD
Pemetrexed—ATIC—smooth muscle tissue—uterine cancer	0.0067	0.0233	CbGeAlD
Pemetrexed—ATIC—renal system—uterine cancer	0.00645	0.0224	CbGeAlD
Pemetrexed—DHFR—myometrium—uterine cancer	0.00595	0.0207	CbGeAlD
Pemetrexed—ATIC—uterus—uterine cancer	0.00575	0.02	CbGeAlD
Pemetrexed—SLC46A1—female gonad—uterine cancer	0.00562	0.0195	CbGeAlD
Pemetrexed—SLC29A1—myometrium—uterine cancer	0.00539	0.0187	CbGeAlD
Pemetrexed—ATIC—female reproductive system—uterine cancer	0.00516	0.018	CbGeAlD
Pemetrexed—DCK—myometrium—uterine cancer	0.00515	0.0179	CbGeAlD
Pemetrexed—ATIC—female gonad—uterine cancer	0.0047	0.0163	CbGeAlD
Pemetrexed—TYMS—uterine cervix—uterine cancer	0.00468	0.0163	CbGeAlD
Pemetrexed—DHFR—uterine cervix—uterine cancer	0.00463	0.0161	CbGeAlD
Pemetrexed—TYMS—smooth muscle tissue—uterine cancer	0.00454	0.0158	CbGeAlD
Pemetrexed—GART—lymph node—uterine cancer	0.00445	0.0155	CbGeAlD
Pemetrexed—DHFR—decidua—uterine cancer	0.00441	0.0153	CbGeAlD
Pemetrexed—DHFR—renal system—uterine cancer	0.00433	0.0151	CbGeAlD
Pemetrexed—TYMS—endometrium—uterine cancer	0.00423	0.0147	CbGeAlD
Pemetrexed—SLC29A1—uterine cervix—uterine cancer	0.00419	0.0146	CbGeAlD
Pemetrexed—DHFR—endometrium—uterine cancer	0.00419	0.0146	CbGeAlD
Pemetrexed—TYMS—mammalian vulva—uterine cancer	0.00409	0.0142	CbGeAlD
Pemetrexed—DHFR—mammalian vulva—uterine cancer	0.00405	0.0141	CbGeAlD
Pemetrexed—DCK—uterine cervix—uterine cancer	0.004	0.0139	CbGeAlD
Pemetrexed—SLC29A1—decidua—uterine cancer	0.00399	0.0139	CbGeAlD
Pemetrexed—ATIC—Levonorgestrel—Progesterone—uterine cancer	0.00398	0.332	CbGdCrCtD
Pemetrexed—SLC29A1—renal system—uterine cancer	0.00392	0.0136	CbGeAlD
Pemetrexed—Tetrahydrofolic acid—MTHFR—uterine cancer	0.00391	0.373	CrCbGaD
Pemetrexed—Folic Acid—MTHFR—uterine cancer	0.00391	0.373	CrCbGaD
Pemetrexed—DHFR—uterus—uterine cancer	0.00386	0.0134	CbGeAlD
Pemetrexed—DCK—decidua—uterine cancer	0.00382	0.0133	CbGeAlD
Pemetrexed—SLC29A1—endometrium—uterine cancer	0.00379	0.0132	CbGeAlD
Pemetrexed—SLC29A1—mammalian vulva—uterine cancer	0.00367	0.0128	CbGeAlD
Pemetrexed—DCK—endometrium—uterine cancer	0.00362	0.0126	CbGeAlD
Pemetrexed—SLC46A1—lymph node—uterine cancer	0.00361	0.0126	CbGeAlD
Pemetrexed—DCK—mammalian vulva—uterine cancer	0.0035	0.0122	CbGeAlD
Pemetrexed—TYMS—female reproductive system—uterine cancer	0.0035	0.0122	CbGeAlD
Pemetrexed—SLC29A1—uterus—uterine cancer	0.00349	0.0122	CbGeAlD
Pemetrexed—DHFR—female reproductive system—uterine cancer	0.00347	0.0121	CbGeAlD
Pemetrexed—DCK—uterus—uterine cancer	0.00334	0.0116	CbGeAlD
Pemetrexed—TYMS—female gonad—uterine cancer	0.00319	0.0111	CbGeAlD
Pemetrexed—TYMS—vagina—uterine cancer	0.00317	0.011	CbGeAlD
Pemetrexed—DHFR—female gonad—uterine cancer	0.00316	0.011	CbGeAlD
Pemetrexed—SLC29A1—female reproductive system—uterine cancer	0.00314	0.0109	CbGeAlD
Pemetrexed—DHFR—vagina—uterine cancer	0.00314	0.0109	CbGeAlD
Pemetrexed—ATIC—lymph node—uterine cancer	0.00302	0.0105	CbGeAlD
Pemetrexed—DCK—female reproductive system—uterine cancer	0.003	0.0104	CbGeAlD
Pemetrexed—SLC29A1—female gonad—uterine cancer	0.00286	0.00994	CbGeAlD
Pemetrexed—SLC29A1—vagina—uterine cancer	0.00284	0.00988	CbGeAlD
Pemetrexed—DCK—female gonad—uterine cancer	0.00273	0.0095	CbGeAlD
Pemetrexed—DCK—vagina—uterine cancer	0.00271	0.00944	CbGeAlD
Pemetrexed—Methotrexate—MTHFR—uterine cancer	0.00267	0.255	CrCbGaD
Pemetrexed—TYMS—Podofilox—Etoposide—uterine cancer	0.00216	0.18	CbGdCrCtD
Pemetrexed—TYMS—lymph node—uterine cancer	0.00205	0.00713	CbGeAlD
Pemetrexed—DHFR—lymph node—uterine cancer	0.00203	0.00706	CbGeAlD
Pemetrexed—TYMS—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.0019	0.00721	CbGpPWpGaD
Pemetrexed—TYMS—Nucleotide metabolism—RRM2—uterine cancer	0.00189	0.00716	CbGpPWpGaD
Pemetrexed—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	0.00187	0.0071	CbGpPWpGaD
Pemetrexed—SLC29A1—lymph node—uterine cancer	0.00184	0.00639	CbGeAlD
Pemetrexed—SLC46A1—Folate Metabolism—CCL2—uterine cancer	0.00183	0.00693	CbGpPWpGaD
Pemetrexed—DCK—lymph node—uterine cancer	0.00176	0.00611	CbGeAlD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.00173	0.00657	CbGpPWpGaD
Pemetrexed—DHFR—G1/S Transition—RRM2—uterine cancer	0.00166	0.00628	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—TP53—uterine cancer	0.00164	0.00622	CbGpPWpGaD
Pemetrexed—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—uterine cancer	0.00157	0.00595	CbGpPWpGaD
Pemetrexed—DCK—Doxorubicin—Epirubicin—uterine cancer	0.00149	0.125	CbGdCrCtD
Pemetrexed—TYMS—G1/S Transition—RRM2—uterine cancer	0.00145	0.00548	CbGpPWpGaD
Pemetrexed—GART—Metabolism—SRD5A2—uterine cancer	0.00144	0.00545	CbGpPWpGaD
Pemetrexed—GART—Metabolism—NDUFB11—uterine cancer	0.00144	0.00545	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—RRM2—uterine cancer	0.0014	0.00529	CbGpPWpGaD
Pemetrexed—DCK—Epirubicin—Doxorubicin—uterine cancer	0.00138	0.115	CbGdCrCtD
Pemetrexed—TYMS—Circadian rythm related genes—STAR—uterine cancer	0.00136	0.00514	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—MTHFR—uterine cancer	0.00125	0.00475	CbGpPWpGaD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—TP53—uterine cancer	0.00123	0.00464	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—RRM2—uterine cancer	0.00122	0.00462	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.0012	0.00454	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00115	0.00436	CbGpPWpGaD
Pemetrexed—TYMS—Danazol—Progesterone—uterine cancer	0.00111	0.0927	CbGdCrCtD
Pemetrexed—TYMS—Circadian rythm related genes—HNF1B—uterine cancer	0.00111	0.00419	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism of nitric oxide—AKT1—uterine cancer	0.00109	0.00412	CbGpPWpGaD
Pemetrexed—DCK—Levonorgestrel—Progesterone—uterine cancer	0.00106	0.0882	CbGdCrCtD
Pemetrexed—GART—Metabolism—AKR1B1—uterine cancer	0.00104	0.00394	CbGpPWpGaD
Pemetrexed—GART—Metabolism—STAR—uterine cancer	0.00104	0.00394	CbGpPWpGaD
Pemetrexed—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	0.001	0.0038	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—SRD5A2—uterine cancer	0.000997	0.00378	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—NDUFB11—uterine cancer	0.000997	0.00378	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—CCL2—uterine cancer	0.000981	0.00371	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000951	0.0036	CbGpPWpGaD
Pemetrexed—Infestation—Etoposide—uterine cancer	0.000933	0.00219	CcSEcCtD
Pemetrexed—Anaemia—Dactinomycin—uterine cancer	0.000931	0.00219	CcSEcCtD
Pemetrexed—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000928	0.00218	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000925	0.00217	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—MLH3—uterine cancer	0.000925	0.0035	CbGpPWpGaD
Pemetrexed—Urticaria—Progesterone—uterine cancer	0.000924	0.00217	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Etoposide—uterine cancer	0.00092	0.00216	CcSEcCtD
Pemetrexed—Abdominal pain—Progesterone—uterine cancer	0.00092	0.00216	CcSEcCtD
Pemetrexed—Body temperature increased—Progesterone—uterine cancer	0.00092	0.00216	CcSEcCtD
Pemetrexed—Renal failure—Etoposide—uterine cancer	0.000917	0.00215	CcSEcCtD
Pemetrexed—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000917	0.00215	CcSEcCtD
Pemetrexed—Myocardial infarction—Etoposide—uterine cancer	0.000915	0.00215	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Etoposide—uterine cancer	0.000915	0.00215	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00091	0.00214	CcSEcCtD
Pemetrexed—Stomatitis—Etoposide—uterine cancer	0.00091	0.00214	CcSEcCtD
Pemetrexed—Creatinine increased—Doxorubicin—uterine cancer	0.000909	0.00213	CcSEcCtD
Pemetrexed—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000909	0.00213	CcSEcCtD
Pemetrexed—Leukopenia—Dactinomycin—uterine cancer	0.000902	0.00212	CcSEcCtD
Pemetrexed—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000902	0.00212	CcSEcCtD
Pemetrexed—Colitis—Epirubicin—uterine cancer	0.000898	0.00211	CcSEcCtD
Pemetrexed—Skin exfoliation—Epirubicin—uterine cancer	0.000893	0.0021	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—TP53—uterine cancer	0.000887	0.00336	CbGpPWpGaD
Pemetrexed—Hepatobiliary disease—Etoposide—uterine cancer	0.000883	0.00207	CcSEcCtD
Pemetrexed—Neuropathy—Epirubicin—uterine cancer	0.000878	0.00206	CcSEcCtD
Pemetrexed—Agranulocytosis—Etoposide—uterine cancer	0.000871	0.00204	CcSEcCtD
Pemetrexed—Pulmonary embolism—Doxorubicin—uterine cancer	0.000865	0.00203	CcSEcCtD
Pemetrexed—Ventricular tachycardia—Doxorubicin—uterine cancer	0.000865	0.00203	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000862	0.00202	CcSEcCtD
Pemetrexed—Myalgia—Dactinomycin—uterine cancer	0.000858	0.00201	CcSEcCtD
Pemetrexed—Hypersensitivity—Progesterone—uterine cancer	0.000857	0.00201	CcSEcCtD
Pemetrexed—Oesophagitis—Epirubicin—uterine cancer	0.000855	0.00201	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	0.000843	0.00319	CbGpPWpGaD
Pemetrexed—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000838	0.00197	CcSEcCtD
Pemetrexed—Asthenia—Progesterone—uterine cancer	0.000835	0.00196	CcSEcCtD
Pemetrexed—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000834	0.00196	CcSEcCtD
Pemetrexed—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000834	0.00196	CcSEcCtD
Pemetrexed—Colitis—Doxorubicin—uterine cancer	0.000831	0.00195	CcSEcCtD
Pemetrexed—DHFR—Fluoropyrimidine Activity—TP53—uterine cancer	0.000828	0.00314	CbGpPWpGaD
Pemetrexed—Urinary tract disorder—Etoposide—uterine cancer	0.000827	0.00194	CcSEcCtD
Pemetrexed—Skin exfoliation—Doxorubicin—uterine cancer	0.000826	0.00194	CcSEcCtD
Pemetrexed—Pruritus—Progesterone—uterine cancer	0.000823	0.00193	CcSEcCtD
Pemetrexed—Oedema—Dactinomycin—uterine cancer	0.000822	0.00193	CcSEcCtD
Pemetrexed—Urethral disorder—Etoposide—uterine cancer	0.000821	0.00193	CcSEcCtD
Pemetrexed—Infection—Dactinomycin—uterine cancer	0.000817	0.00192	CcSEcCtD
Pemetrexed—GART—Metabolism—POLD1—uterine cancer	0.000816	0.00309	CbGpPWpGaD
Pemetrexed—Neuropathy—Doxorubicin—uterine cancer	0.000812	0.00191	CcSEcCtD
Pemetrexed—Sepsis—Epirubicin—uterine cancer	0.000812	0.00191	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—MLH3—uterine cancer	0.000807	0.00306	CbGpPWpGaD
Pemetrexed—Thrombocytopenia—Dactinomycin—uterine cancer	0.000805	0.00189	CcSEcCtD
Pemetrexed—Diarrhoea—Progesterone—uterine cancer	0.000796	0.00187	CcSEcCtD
Pemetrexed—TYMS—Levonorgestrel—Progesterone—uterine cancer	0.000795	0.0664	CbGdCrCtD
Pemetrexed—Erythema multiforme—Etoposide—uterine cancer	0.000792	0.00186	CcSEcCtD
Pemetrexed—Oesophagitis—Doxorubicin—uterine cancer	0.000791	0.00186	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—CDKN2A—uterine cancer	0.000789	0.00299	CbGpPWpGaD
Pemetrexed—Anorexia—Dactinomycin—uterine cancer	0.000784	0.00184	CcSEcCtD
Pemetrexed—Eye disorder—Etoposide—uterine cancer	0.000783	0.00184	CcSEcCtD
Pemetrexed—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000777	0.00182	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—SRD5A2—uterine cancer	0.000777	0.00294	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—NDUFB11—uterine cancer	0.000777	0.00294	CbGpPWpGaD
Pemetrexed—Dizziness—Progesterone—uterine cancer	0.000769	0.00181	CcSEcCtD
Pemetrexed—GART—Metabolism—AKR1C1—uterine cancer	0.000763	0.00289	CbGpPWpGaD
Pemetrexed—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000757	0.00178	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000755	0.00286	CbGpPWpGaD
Pemetrexed—Sepsis—Doxorubicin—uterine cancer	0.000751	0.00176	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000749	0.00176	CcSEcCtD
Pemetrexed—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000746	0.00175	CcSEcCtD
Pemetrexed—Alopecia—Etoposide—uterine cancer	0.00074	0.00174	CcSEcCtD
Pemetrexed—Vomiting—Progesterone—uterine cancer	0.00074	0.00174	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000739	0.0028	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	0.000736	0.00279	CbGpPWpGaD
Pemetrexed—Renal failure acute—Epirubicin—uterine cancer	0.000735	0.00173	CcSEcCtD
Pemetrexed—Rash—Progesterone—uterine cancer	0.000734	0.00172	CcSEcCtD
Pemetrexed—Dermatitis—Progesterone—uterine cancer	0.000733	0.00172	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000723	0.00274	CbGpPWpGaD
Pemetrexed—TYMS—Fluoropyrimidine Activity—TP53—uterine cancer	0.000723	0.00274	CbGpPWpGaD
Pemetrexed—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000721	0.00169	CcSEcCtD
Pemetrexed—SLC46A1—Disease—AKR1B10—uterine cancer	0.000721	0.00273	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AKR1B1—uterine cancer	0.000721	0.00273	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—STAR—uterine cancer	0.000721	0.00273	CbGpPWpGaD
Pemetrexed—Decreased appetite—Dactinomycin—uterine cancer	0.000715	0.00168	CcSEcCtD
Pemetrexed—Dysgeusia—Etoposide—uterine cancer	0.000714	0.00168	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—EZH2—uterine cancer	0.000709	0.00269	CbGpPWpGaD
Pemetrexed—Fatigue—Dactinomycin—uterine cancer	0.000709	0.00166	CcSEcCtD
Pemetrexed—Pain—Dactinomycin—uterine cancer	0.000703	0.00165	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—CDKN1B—uterine cancer	0.000699	0.00265	CbGpPWpGaD
Pemetrexed—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000697	0.00164	CcSEcCtD
Pemetrexed—Cerebrovascular accident—Epirubicin—uterine cancer	0.000693	0.00163	CcSEcCtD
Pemetrexed—Nausea—Progesterone—uterine cancer	0.000691	0.00162	CcSEcCtD
Pemetrexed—TYMS—E2F transcription factor network—CDKN2A—uterine cancer	0.000688	0.00261	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000685	0.00259	CbGpPWpGaD
Pemetrexed—Renal failure acute—Doxorubicin—uterine cancer	0.00068	0.0016	CcSEcCtD
Pemetrexed—GART—Metabolism—RRM2—uterine cancer	0.00068	0.00258	CbGpPWpGaD
Pemetrexed—Anaemia—Etoposide—uterine cancer	0.000674	0.00158	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000673	0.00158	CcSEcCtD
Pemetrexed—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00067	0.00157	CcSEcCtD
Pemetrexed—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000665	0.00156	CcSEcCtD
Pemetrexed—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000664	0.00156	CcSEcCtD
Pemetrexed—GART—Metabolism—DCN—uterine cancer	0.00066	0.0025	CbGpPWpGaD
Pemetrexed—Leukopenia—Etoposide—uterine cancer	0.000653	0.00153	CcSEcCtD
Pemetrexed—Abdominal pain—Dactinomycin—uterine cancer	0.00065	0.00153	CcSEcCtD
Pemetrexed—Body temperature increased—Dactinomycin—uterine cancer	0.00065	0.00153	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—NDC80—uterine cancer	0.000647	0.00245	CbGpPWpGaD
Pemetrexed—Mood swings—Epirubicin—uterine cancer	0.000643	0.00151	CcSEcCtD
Pemetrexed—Loss of consciousness—Etoposide—uterine cancer	0.000641	0.0015	CcSEcCtD
Pemetrexed—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000641	0.0015	CcSEcCtD
Pemetrexed—Blood creatinine increased—Epirubicin—uterine cancer	0.000636	0.00149	CcSEcCtD
Pemetrexed—Dehydration—Epirubicin—uterine cancer	0.000631	0.00148	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000631	0.00239	CbGpPWpGaD
Pemetrexed—Hypertension—Etoposide—uterine cancer	0.00063	0.00148	CcSEcCtD
Pemetrexed—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000626	0.00147	CcSEcCtD
Pemetrexed—GART—Metabolism—CYP11A1—uterine cancer	0.000622	0.00236	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000622	0.00236	CbGpPWpGaD
Pemetrexed—Chest pain—Etoposide—uterine cancer	0.000621	0.00146	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000617	0.00145	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000615	0.00233	CbGpPWpGaD
Pemetrexed—DHFR—E2F transcription factor network—EP300—uterine cancer	0.000613	0.00232	CbGpPWpGaD
Pemetrexed—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000611	0.00144	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000611	0.00144	CcSEcCtD
Pemetrexed—TYMS—E2F transcription factor network—CDKN1B—uterine cancer	0.000609	0.00231	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000607	0.0023	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Dactinomycin—uterine cancer	0.000606	0.00142	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000599	0.00141	CcSEcCtD
Pemetrexed—SLC46A1—Disease—RNF43—uterine cancer	0.000598	0.00226	CbGpPWpGaD
Pemetrexed—Anaphylactic shock—Etoposide—uterine cancer	0.000595	0.0014	CcSEcCtD
Pemetrexed—Mood swings—Doxorubicin—uterine cancer	0.000595	0.0014	CcSEcCtD
Pemetrexed—Infection—Etoposide—uterine cancer	0.000591	0.00139	CcSEcCtD
Pemetrexed—Asthenia—Dactinomycin—uterine cancer	0.00059	0.00139	CcSEcCtD
Pemetrexed—Blood creatinine increased—Doxorubicin—uterine cancer	0.000588	0.00138	CcSEcCtD
Pemetrexed—GART—Metabolism—AKR1C3—uterine cancer	0.000588	0.00223	CbGpPWpGaD
Pemetrexed—Dysphagia—Epirubicin—uterine cancer	0.000587	0.00138	CcSEcCtD
Pemetrexed—Dehydration—Doxorubicin—uterine cancer	0.000584	0.00137	CcSEcCtD
Pemetrexed—Thrombocytopenia—Etoposide—uterine cancer	0.000583	0.00137	CcSEcCtD
Pemetrexed—Skin disorder—Etoposide—uterine cancer	0.000578	0.00136	CcSEcCtD
Pemetrexed—Pancreatitis—Epirubicin—uterine cancer	0.000575	0.00135	CcSEcCtD
Pemetrexed—Angina pectoris—Epirubicin—uterine cancer	0.000572	0.00134	CcSEcCtD
Pemetrexed—Anorexia—Etoposide—uterine cancer	0.000567	0.00133	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000566	0.00133	CcSEcCtD
Pemetrexed—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000566	0.00133	CcSEcCtD
Pemetrexed—ATIC—Metabolism—POLD1—uterine cancer	0.000566	0.00214	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—NDC80—uterine cancer	0.000564	0.00214	CbGpPWpGaD
Pemetrexed—Diarrhoea—Dactinomycin—uterine cancer	0.000563	0.00132	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—STAR—uterine cancer	0.000562	0.00213	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AKR1B1—uterine cancer	0.000562	0.00213	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000558	0.00211	CbGpPWpGaD
Pemetrexed—Pancytopenia—Epirubicin—uterine cancer	0.000557	0.00131	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000554	0.0013	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—POLD1—uterine cancer	0.00055	0.00208	CbGpPWpGaD
Pemetrexed—Neutropenia—Epirubicin—uterine cancer	0.000549	0.00129	CcSEcCtD
Pemetrexed—Dysphagia—Doxorubicin—uterine cancer	0.000543	0.00127	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000537	0.00203	CbGpPWpGaD
Pemetrexed—TYMS—E2F transcription factor network—EP300—uterine cancer	0.000535	0.00203	CbGpPWpGaD
Pemetrexed—Pancreatitis—Doxorubicin—uterine cancer	0.000532	0.00125	CcSEcCtD
Pemetrexed—Dyspnoea—Etoposide—uterine cancer	0.000531	0.00125	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.00053	0.00201	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AKR1C1—uterine cancer	0.000529	0.002	CbGpPWpGaD
Pemetrexed—Angina pectoris—Doxorubicin—uterine cancer	0.000529	0.00124	CcSEcCtD
Pemetrexed—Infestation—Epirubicin—uterine cancer	0.000523	0.00123	CcSEcCtD
Pemetrexed—Infestation NOS—Epirubicin—uterine cancer	0.000523	0.00123	CcSEcCtD
Pemetrexed—Vomiting—Dactinomycin—uterine cancer	0.000523	0.00123	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000519	0.00122	CcSEcCtD
Pemetrexed—Rash—Dactinomycin—uterine cancer	0.000519	0.00122	CcSEcCtD
Pemetrexed—DCK—Metabolism—SRD5A2—uterine cancer	0.000518	0.00196	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NDUFB11—uterine cancer	0.000518	0.00196	CbGpPWpGaD
Pemetrexed—Decreased appetite—Etoposide—uterine cancer	0.000517	0.00121	CcSEcCtD
Pemetrexed—Pancytopenia—Doxorubicin—uterine cancer	0.000516	0.00121	CcSEcCtD
Pemetrexed—Renal failure—Epirubicin—uterine cancer	0.000514	0.00121	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Etoposide—uterine cancer	0.000514	0.00121	CcSEcCtD
Pemetrexed—Fatigue—Etoposide—uterine cancer	0.000513	0.0012	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Epirubicin—uterine cancer	0.000513	0.0012	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000513	0.00194	CbGpPWpGaD
Pemetrexed—Stomatitis—Epirubicin—uterine cancer	0.00051	0.0012	CcSEcCtD
Pemetrexed—Pain—Etoposide—uterine cancer	0.000509	0.00119	CcSEcCtD
Pemetrexed—Constipation—Etoposide—uterine cancer	0.000509	0.00119	CcSEcCtD
Pemetrexed—Conjunctivitis—Epirubicin—uterine cancer	0.000509	0.00119	CcSEcCtD
Pemetrexed—Neutropenia—Doxorubicin—uterine cancer	0.000508	0.00119	CcSEcCtD
Pemetrexed—DHFR—G1/S Transition—CDKN1B—uterine cancer	0.000507	0.00192	CbGpPWpGaD
Pemetrexed—Hepatobiliary disease—Epirubicin—uterine cancer	0.000495	0.00116	CcSEcCtD
Pemetrexed—SLC46A1—Disease—AKR1C1—uterine cancer	0.000492	0.00186	CbGpPWpGaD
Pemetrexed—Nausea—Dactinomycin—uterine cancer	0.000489	0.00115	CcSEcCtD
Pemetrexed—Agranulocytosis—Epirubicin—uterine cancer	0.000488	0.00115	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Etoposide—uterine cancer	0.000487	0.00114	CcSEcCtD
Pemetrexed—Infestation—Doxorubicin—uterine cancer	0.000484	0.00114	CcSEcCtD
Pemetrexed—Infestation NOS—Doxorubicin—uterine cancer	0.000484	0.00114	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.000482	0.00183	CbGpPWpGaD
Pemetrexed—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00048	0.00113	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—POLD1—uterine cancer	0.00048	0.00182	CbGpPWpGaD
Pemetrexed—Renal failure—Doxorubicin—uterine cancer	0.000476	0.00112	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—TP53—uterine cancer	0.000476	0.0018	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000475	0.0018	CbGpPWpGaD
Pemetrexed—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000475	0.00111	CcSEcCtD
Pemetrexed—Urticaria—Etoposide—uterine cancer	0.000473	0.00111	CcSEcCtD
Pemetrexed—Stomatitis—Doxorubicin—uterine cancer	0.000472	0.00111	CcSEcCtD
Pemetrexed—ATIC—Metabolism—RRM2—uterine cancer	0.000472	0.00179	CbGpPWpGaD
Pemetrexed—Body temperature increased—Etoposide—uterine cancer	0.000471	0.0011	CcSEcCtD
Pemetrexed—Abdominal pain—Etoposide—uterine cancer	0.000471	0.0011	CcSEcCtD
Pemetrexed—Conjunctivitis—Doxorubicin—uterine cancer	0.000471	0.0011	CcSEcCtD
Pemetrexed—Hepatitis—Epirubicin—uterine cancer	0.00047	0.0011	CcSEcCtD
Pemetrexed—Pharyngitis—Epirubicin—uterine cancer	0.000466	0.00109	CcSEcCtD
Pemetrexed—Urinary tract disorder—Epirubicin—uterine cancer	0.000464	0.00109	CcSEcCtD
Pemetrexed—Urethral disorder—Epirubicin—uterine cancer	0.00046	0.00108	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—RRM2—uterine cancer	0.000458	0.00174	CbGpPWpGaD
Pemetrexed—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000458	0.00107	CcSEcCtD
Pemetrexed—ATIC—Metabolism—DCN—uterine cancer	0.000458	0.00173	CbGpPWpGaD
Pemetrexed—GART—Metabolism—STK11—uterine cancer	0.000458	0.00173	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CYP19A1—uterine cancer	0.000458	0.00173	CbGpPWpGaD
Pemetrexed—Agranulocytosis—Doxorubicin—uterine cancer	0.000452	0.00106	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000447	0.00169	CbGpPWpGaD
Pemetrexed—Erythema multiforme—Epirubicin—uterine cancer	0.000444	0.00104	CcSEcCtD
Pemetrexed—TYMS—G1/S Transition—CDKN1B—uterine cancer	0.000442	0.00167	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—POLD1—uterine cancer	0.000441	0.00167	CbGpPWpGaD
Pemetrexed—Eye disorder—Epirubicin—uterine cancer	0.000439	0.00103	CcSEcCtD
Pemetrexed—Hypersensitivity—Etoposide—uterine cancer	0.000439	0.00103	CcSEcCtD
Pemetrexed—Hepatitis—Doxorubicin—uterine cancer	0.000435	0.00102	CcSEcCtD
Pemetrexed—Pharyngitis—Doxorubicin—uterine cancer	0.000431	0.00101	CcSEcCtD
Pemetrexed—ATIC—Metabolism—CYP11A1—uterine cancer	0.000431	0.00163	CbGpPWpGaD
Pemetrexed—Urinary tract disorder—Doxorubicin—uterine cancer	0.000429	0.00101	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000427	0.00162	CbGpPWpGaD
Pemetrexed—Asthenia—Etoposide—uterine cancer	0.000427	0.001	CcSEcCtD
Pemetrexed—Urethral disorder—Doxorubicin—uterine cancer	0.000426	0.001	CcSEcCtD
Pemetrexed—SLC46A1—Disease—DCN—uterine cancer	0.000426	0.00161	CbGpPWpGaD
Pemetrexed—Pruritus—Etoposide—uterine cancer	0.000421	0.000989	CcSEcCtD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.000421	0.00159	CbGpPWpGaD
Pemetrexed—Arrhythmia—Epirubicin—uterine cancer	0.00042	0.000985	CcSEcCtD
Pemetrexed—DHFR—Metabolism—NDUFB11—uterine cancer	0.000416	0.00158	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SRD5A2—uterine cancer	0.000416	0.00158	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000415	0.00157	CbGpPWpGaD
Pemetrexed—Alopecia—Epirubicin—uterine cancer	0.000415	0.000974	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—AKR1C1—uterine cancer	0.000412	0.00156	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000412	0.00156	CbGpPWpGaD
Pemetrexed—Erythema multiforme—Doxorubicin—uterine cancer	0.000411	0.000965	CcSEcCtD
Pemetrexed—Malnutrition—Epirubicin—uterine cancer	0.000409	0.00096	CcSEcCtD
Pemetrexed—Erythema—Epirubicin—uterine cancer	0.000409	0.00096	CcSEcCtD
Pemetrexed—ATIC—Metabolism—AKR1C3—uterine cancer	0.000407	0.00154	CbGpPWpGaD
Pemetrexed—Diarrhoea—Etoposide—uterine cancer	0.000407	0.000956	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—MLH1—uterine cancer	0.000407	0.00154	CbGpPWpGaD
Pemetrexed—Eye disorder—Doxorubicin—uterine cancer	0.000406	0.000953	CcSEcCtD
Pemetrexed—Dysgeusia—Epirubicin—uterine cancer	0.0004	0.00094	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—RRM2—uterine cancer	0.0004	0.00151	CbGpPWpGaD
Pemetrexed—Dizziness—Etoposide—uterine cancer	0.000394	0.000924	CcSEcCtD
Pemetrexed—Arrhythmia—Doxorubicin—uterine cancer	0.000388	0.000911	CcSEcCtD
Pemetrexed—DHFR—Disease—AKR1B10—uterine cancer	0.000387	0.00146	CbGpPWpGaD
Pemetrexed—Alopecia—Doxorubicin—uterine cancer	0.000384	0.000901	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000381	0.00144	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKR1C3—uterine cancer	0.000379	0.00143	CbGpPWpGaD
Pemetrexed—Vomiting—Etoposide—uterine cancer	0.000378	0.000888	CcSEcCtD
Pemetrexed—Malnutrition—Doxorubicin—uterine cancer	0.000378	0.000888	CcSEcCtD
Pemetrexed—Erythema—Doxorubicin—uterine cancer	0.000378	0.000888	CcSEcCtD
Pemetrexed—Anaemia—Epirubicin—uterine cancer	0.000378	0.000887	CcSEcCtD
Pemetrexed—Rash—Etoposide—uterine cancer	0.000375	0.000881	CcSEcCtD
Pemetrexed—Dermatitis—Etoposide—uterine cancer	0.000375	0.00088	CcSEcCtD
Pemetrexed—DCK—Metabolism—STAR—uterine cancer	0.000375	0.00142	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AKR1B1—uterine cancer	0.000375	0.00142	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000373	0.00141	CbGpPWpGaD
Pemetrexed—Dysgeusia—Doxorubicin—uterine cancer	0.00037	0.00087	CcSEcCtD
Pemetrexed—SLC46A1—Disease—HMGA1—uterine cancer	0.000369	0.0014	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—YWHAE—uterine cancer	0.000368	0.00139	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—RRM2—uterine cancer	0.000367	0.00139	CbGpPWpGaD
Pemetrexed—Syncope—Epirubicin—uterine cancer	0.000367	0.000861	CcSEcCtD
Pemetrexed—Leukopenia—Epirubicin—uterine cancer	0.000366	0.000859	CcSEcCtD
Pemetrexed—TYMS—Metabolism—NDUFB11—uterine cancer	0.000363	0.00138	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SRD5A2—uterine cancer	0.000363	0.00138	CbGpPWpGaD
Pemetrexed—Loss of consciousness—Epirubicin—uterine cancer	0.000359	0.000844	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000359	0.00136	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—DCN—uterine cancer	0.000357	0.00135	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MLH1—uterine cancer	0.000355	0.00135	CbGpPWpGaD
Pemetrexed—Nausea—Etoposide—uterine cancer	0.000354	0.00083	CcSEcCtD
Pemetrexed—Hypertension—Epirubicin—uterine cancer	0.000353	0.000829	CcSEcCtD
Pemetrexed—Anaemia—Doxorubicin—uterine cancer	0.00035	0.000821	CcSEcCtD
Pemetrexed—Chest pain—Epirubicin—uterine cancer	0.000348	0.000817	CcSEcCtD
Pemetrexed—Arthralgia—Epirubicin—uterine cancer	0.000348	0.000817	CcSEcCtD
Pemetrexed—Myalgia—Epirubicin—uterine cancer	0.000348	0.000817	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000346	0.000811	CcSEcCtD
Pemetrexed—GART—Metabolism—MTHFR—uterine cancer	0.000344	0.0013	CbGpPWpGaD
Pemetrexed—Syncope—Doxorubicin—uterine cancer	0.000339	0.000796	CcSEcCtD
Pemetrexed—Leukopenia—Doxorubicin—uterine cancer	0.000339	0.000795	CcSEcCtD
Pemetrexed—SLC46A1—Disease—FBXW7—uterine cancer	0.000338	0.00128	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP11A1—uterine cancer	0.000336	0.00127	CbGpPWpGaD
Pemetrexed—Anaphylactic shock—Epirubicin—uterine cancer	0.000334	0.000783	CcSEcCtD
Pemetrexed—Oedema—Epirubicin—uterine cancer	0.000334	0.000783	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000333	0.00126	CbGpPWpGaD
Pemetrexed—Loss of consciousness—Doxorubicin—uterine cancer	0.000332	0.00078	CcSEcCtD
Pemetrexed—Infection—Epirubicin—uterine cancer	0.000331	0.000778	CcSEcCtD
Pemetrexed—Shock—Epirubicin—uterine cancer	0.000328	0.000771	CcSEcCtD
Pemetrexed—Nervous system disorder—Epirubicin—uterine cancer	0.000327	0.000768	CcSEcCtD
Pemetrexed—Thrombocytopenia—Epirubicin—uterine cancer	0.000327	0.000767	CcSEcCtD
Pemetrexed—Hypertension—Doxorubicin—uterine cancer	0.000327	0.000767	CcSEcCtD
Pemetrexed—Skin disorder—Epirubicin—uterine cancer	0.000324	0.000761	CcSEcCtD
Pemetrexed—Myalgia—Doxorubicin—uterine cancer	0.000322	0.000756	CcSEcCtD
Pemetrexed—Arthralgia—Doxorubicin—uterine cancer	0.000322	0.000756	CcSEcCtD
Pemetrexed—Chest pain—Doxorubicin—uterine cancer	0.000322	0.000756	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—YWHAE—uterine cancer	0.000321	0.00122	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RNF43—uterine cancer	0.00032	0.00121	CbGpPWpGaD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00032	0.000751	CcSEcCtD
Pemetrexed—Anorexia—Epirubicin—uterine cancer	0.000318	0.000747	CcSEcCtD
Pemetrexed—ATIC—Metabolism—CYP19A1—uterine cancer	0.000317	0.0012	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—STK11—uterine cancer	0.000317	0.0012	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AKR1C3—uterine cancer	0.000317	0.0012	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000309	0.00117	CbGpPWpGaD
Pemetrexed—Anaphylactic shock—Doxorubicin—uterine cancer	0.000309	0.000725	CcSEcCtD
Pemetrexed—Oedema—Doxorubicin—uterine cancer	0.000309	0.000725	CcSEcCtD
Pemetrexed—Infection—Doxorubicin—uterine cancer	0.000307	0.00072	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000305	0.00115	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000304	0.000714	CcSEcCtD
Pemetrexed—Shock—Doxorubicin—uterine cancer	0.000304	0.000713	CcSEcCtD
Pemetrexed—Nervous system disorder—Doxorubicin—uterine cancer	0.000303	0.000711	CcSEcCtD
Pemetrexed—Thrombocytopenia—Doxorubicin—uterine cancer	0.000302	0.00071	CcSEcCtD
Pemetrexed—DHFR—Metabolism—STAR—uterine cancer	0.000301	0.00114	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKR1B1—uterine cancer	0.000301	0.00114	CbGpPWpGaD
Pemetrexed—Skin disorder—Doxorubicin—uterine cancer	0.0003	0.000704	CcSEcCtD
Pemetrexed—Dyspnoea—Epirubicin—uterine cancer	0.000297	0.000698	CcSEcCtD
Pemetrexed—Anorexia—Doxorubicin—uterine cancer	0.000294	0.000691	CcSEcCtD
Pemetrexed—DCK—Metabolism—POLD1—uterine cancer	0.000294	0.00111	CbGpPWpGaD
Pemetrexed—Dyspepsia—Epirubicin—uterine cancer	0.000294	0.000689	CcSEcCtD
Pemetrexed—Decreased appetite—Epirubicin—uterine cancer	0.00029	0.000681	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000288	0.000676	CcSEcCtD
Pemetrexed—Fatigue—Epirubicin—uterine cancer	0.000288	0.000675	CcSEcCtD
Pemetrexed—Pain—Epirubicin—uterine cancer	0.000285	0.00067	CcSEcCtD
Pemetrexed—Constipation—Epirubicin—uterine cancer	0.000285	0.00067	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000282	0.00107	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000281	0.00066	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—CDKN2B—uterine cancer	0.000277	0.00105	CbGpPWpGaD
Pemetrexed—Dyspnoea—Doxorubicin—uterine cancer	0.000275	0.000646	CcSEcCtD
Pemetrexed—DCK—Metabolism—AKR1C1—uterine cancer	0.000275	0.00104	CbGpPWpGaD
Pemetrexed—Gastrointestinal pain—Epirubicin—uterine cancer	0.000273	0.00064	CcSEcCtD
Pemetrexed—Dyspepsia—Doxorubicin—uterine cancer	0.000272	0.000638	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.00027	0.00102	CbGpPWpGaD
Pemetrexed—Decreased appetite—Doxorubicin—uterine cancer	0.000268	0.00063	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000267	0.00101	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000267	0.00101	CbGpPWpGaD
Pemetrexed—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000267	0.000626	CcSEcCtD
Pemetrexed—Fatigue—Doxorubicin—uterine cancer	0.000266	0.000625	CcSEcCtD
Pemetrexed—Urticaria—Epirubicin—uterine cancer	0.000265	0.000622	CcSEcCtD
Pemetrexed—SLC46A1—Disease—CDKN2B—uterine cancer	0.000265	0.001	CbGpPWpGaD
Pemetrexed—Pain—Doxorubicin—uterine cancer	0.000264	0.00062	CcSEcCtD
Pemetrexed—Constipation—Doxorubicin—uterine cancer	0.000264	0.00062	CcSEcCtD
Pemetrexed—DHFR—Disease—AKR1C1—uterine cancer	0.000264	0.000999	CbGpPWpGaD
Pemetrexed—Abdominal pain—Epirubicin—uterine cancer	0.000264	0.000619	CcSEcCtD
Pemetrexed—Body temperature increased—Epirubicin—uterine cancer	0.000264	0.000619	CcSEcCtD
Pemetrexed—TYMS—Metabolism—STAR—uterine cancer	0.000263	0.000995	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKR1B1—uterine cancer	0.000263	0.000995	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.00026	0.000985	CbGpPWpGaD
Pemetrexed—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000252	0.000593	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—PTEN—uterine cancer	0.00025	0.000945	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000248	0.000939	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—STK11—uterine cancer	0.000247	0.000936	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP19A1—uterine cancer	0.000247	0.000936	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Epirubicin—uterine cancer	0.000246	0.000577	CcSEcCtD
Pemetrexed—Urticaria—Doxorubicin—uterine cancer	0.000245	0.000576	CcSEcCtD
Pemetrexed—DCK—Metabolism—RRM2—uterine cancer	0.000245	0.000928	CbGpPWpGaD
Pemetrexed—Abdominal pain—Doxorubicin—uterine cancer	0.000244	0.000573	CcSEcCtD
Pemetrexed—Body temperature increased—Doxorubicin—uterine cancer	0.000244	0.000573	CcSEcCtD
Pemetrexed—SLC46A1—Disease—SMAD3—uterine cancer	0.000242	0.000915	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2B—uterine cancer	0.000241	0.000914	CbGpPWpGaD
Pemetrexed—Asthenia—Epirubicin—uterine cancer	0.000239	0.000562	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—BIRC5—uterine cancer	0.000239	0.000904	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—MTHFR—uterine cancer	0.000238	0.000903	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—EP300—uterine cancer	0.000238	0.000901	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—DCN—uterine cancer	0.000238	0.000901	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—POLD1—uterine cancer	0.000236	0.000895	CbGpPWpGaD
Pemetrexed—Pruritus—Epirubicin—uterine cancer	0.000236	0.000554	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000235	0.000889	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000233	0.000882	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FGFR2—uterine cancer	0.00023	0.000873	CbGpPWpGaD
Pemetrexed—DHFR—Disease—DCN—uterine cancer	0.000228	0.000865	CbGpPWpGaD
Pemetrexed—Diarrhoea—Epirubicin—uterine cancer	0.000228	0.000536	CcSEcCtD
Pemetrexed—Hypersensitivity—Doxorubicin—uterine cancer	0.000227	0.000534	CcSEcCtD
Pemetrexed—DCK—Metabolism—CYP11A1—uterine cancer	0.000224	0.000849	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MTHFR—uterine cancer	0.000222	0.00084	CbGpPWpGaD
Pemetrexed—Asthenia—Doxorubicin—uterine cancer	0.000222	0.00052	CcSEcCtD
Pemetrexed—DHFR—Metabolism—AKR1C1—uterine cancer	0.000221	0.000837	CbGpPWpGaD
Pemetrexed—Dizziness—Epirubicin—uterine cancer	0.000221	0.000518	CcSEcCtD
Pemetrexed—Pruritus—Doxorubicin—uterine cancer	0.000218	0.000513	CcSEcCtD
Pemetrexed—Vomiting—Epirubicin—uterine cancer	0.000212	0.000498	CcSEcCtD
Pemetrexed—DCK—Metabolism—AKR1C3—uterine cancer	0.000212	0.000802	CbGpPWpGaD
Pemetrexed—Diarrhoea—Doxorubicin—uterine cancer	0.000211	0.000496	CcSEcCtD
Pemetrexed—Rash—Epirubicin—uterine cancer	0.00021	0.000494	CcSEcCtD
Pemetrexed—Dermatitis—Epirubicin—uterine cancer	0.00021	0.000493	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—BIRC5—uterine cancer	0.000208	0.000789	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—POLD1—uterine cancer	0.000206	0.000781	CbGpPWpGaD
Pemetrexed—Dizziness—Doxorubicin—uterine cancer	0.000204	0.000479	CcSEcCtD
Pemetrexed—DHFR—Disease—AKR1C3—uterine cancer	0.000203	0.000769	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.0002	0.000756	CbGpPWpGaD
Pemetrexed—Nausea—Epirubicin—uterine cancer	0.000198	0.000465	CcSEcCtD
Pemetrexed—DHFR—Disease—HMGA1—uterine cancer	0.000198	0.00075	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—RRM2—uterine cancer	0.000197	0.000746	CbGpPWpGaD
Pemetrexed—Vomiting—Doxorubicin—uterine cancer	0.000196	0.000461	CcSEcCtD
Pemetrexed—Rash—Doxorubicin—uterine cancer	0.000195	0.000457	CcSEcCtD
Pemetrexed—Dermatitis—Doxorubicin—uterine cancer	0.000194	0.000457	CcSEcCtD
Pemetrexed—TYMS—Metabolism—AKR1C1—uterine cancer	0.000193	0.00073	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTEN—uterine cancer	0.000191	0.000725	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—DCN—uterine cancer	0.000191	0.000724	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—MTHFR—uterine cancer	0.000186	0.000703	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000183	0.000695	CbGpPWpGaD
Pemetrexed—Nausea—Doxorubicin—uterine cancer	0.000183	0.00043	CcSEcCtD
Pemetrexed—GART—Metabolism—EP300—uterine cancer	0.000183	0.000691	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FBXW7—uterine cancer	0.000181	0.000686	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP11A1—uterine cancer	0.00018	0.000682	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000177	0.000672	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2A—uterine cancer	0.000177	0.00067	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—RRM2—uterine cancer	0.000172	0.000651	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—uterine cancer	0.00017	0.000645	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKR1C3—uterine cancer	0.00017	0.000644	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—DCN—uterine cancer	0.000167	0.000632	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—STK11—uterine cancer	0.000165	0.000625	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP19A1—uterine cancer	0.000165	0.000625	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN2A—uterine cancer	0.000158	0.000599	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP11A1—uterine cancer	0.000157	0.000595	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN1B—uterine cancer	0.000157	0.000593	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—uterine cancer	0.000154	0.000584	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.00015	0.000567	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKR1C3—uterine cancer	0.000148	0.000562	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ERBB2—uterine cancer	0.000145	0.000548	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN2B—uterine cancer	0.000142	0.000537	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN1B—uterine cancer	0.00014	0.00053	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2A—uterine cancer	0.000138	0.000523	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—EP300—uterine cancer	0.000138	0.000521	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN1B—uterine cancer	0.000137	0.000518	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CA—uterine cancer	0.000135	0.000511	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CDKN1B—uterine cancer	0.000134	0.000507	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTEN—uterine cancer	0.000133	0.000502	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—STK11—uterine cancer	0.000133	0.000502	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP19A1—uterine cancer	0.000133	0.000502	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SMAD3—uterine cancer	0.00013	0.000491	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CTNNB1—uterine cancer	0.000127	0.000479	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—EP300—uterine cancer	0.000127	0.000479	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—MTHFR—uterine cancer	0.000124	0.000469	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGFR2—uterine cancer	0.000124	0.000468	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTEN—uterine cancer	0.000123	0.000467	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—EP300—uterine cancer	0.000123	0.000466	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN1B—uterine cancer	0.000122	0.000463	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—EP300—uterine cancer	0.00012	0.000455	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTHFR—uterine cancer	0.000119	0.00045	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EP300—uterine cancer	0.000118	0.000446	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP19A1—uterine cancer	0.000116	0.000438	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—STK11—uterine cancer	0.000116	0.000438	CbGpPWpGaD
Pemetrexed—GART—Metabolism—AKT1—uterine cancer	0.00011	0.000418	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NRAS—uterine cancer	0.00011	0.000417	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—EP300—uterine cancer	0.000107	0.000406	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTEN—uterine cancer	0.000103	0.000391	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—MTHFR—uterine cancer	9.96e-05	0.000377	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—EP300—uterine cancer	9.86e-05	0.000373	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—KRAS—uterine cancer	9.48e-05	0.000359	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CA—uterine cancer	9.36e-05	0.000354	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—uterine cancer	8.8e-05	0.000333	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CA—uterine cancer	8.71e-05	0.00033	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MTHFR—uterine cancer	8.69e-05	0.000329	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HRAS—uterine cancer	8.05e-05	0.000305	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB2—uterine cancer	7.76e-05	0.000294	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—uterine cancer	7.68e-05	0.000291	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AKT1—uterine cancer	7.64e-05	0.000289	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CA—uterine cancer	7.29e-05	0.000276	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN1B—uterine cancer	7.19e-05	0.000272	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT1—uterine cancer	7.11e-05	0.000269	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTEN—uterine cancer	6.9e-05	0.000261	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CTNNB1—uterine cancer	6.79e-05	0.000257	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTEN—uterine cancer	6.62e-05	0.000251	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—EP300—uterine cancer	6.58e-05	0.000249	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EP300—uterine cancer	6.31e-05	0.000239	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AKT1—uterine cancer	5.96e-05	0.000226	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NRAS—uterine cancer	5.9e-05	0.000224	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTEN—uterine cancer	5.54e-05	0.00021	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—EP300—uterine cancer	5.28e-05	0.0002	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KRAS—uterine cancer	5.08e-05	0.000192	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CA—uterine cancer	4.86e-05	0.000184	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTEN—uterine cancer	4.83e-05	0.000183	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CA—uterine cancer	4.67e-05	0.000177	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—EP300—uterine cancer	4.61e-05	0.000175	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HRAS—uterine cancer	4.32e-05	0.000164	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AKT1—uterine cancer	3.97e-05	0.00015	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CA—uterine cancer	3.91e-05	0.000148	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT1—uterine cancer	3.81e-05	0.000144	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CA—uterine cancer	3.41e-05	0.000129	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKT1—uterine cancer	3.19e-05	0.000121	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKT1—uterine cancer	2.79e-05	0.000106	CbGpPWpGaD
